Abstract
Lamivudine belongs to the set of antiviral agents effective against hepatitis B virus infection. Given case reports on liver injuries after certain antiviral agent treatments, this study examined the effects of lamivudine on alanine aminotransferase (ALT) and total bilirubin (TB) using a medical system database. A total of 1,321 patients taking lamivudine alone or with others were evaluated using laboratory hits in an electronic medical system at Seoul National University Hospital from 2005 through 2011. The patients were grouped according to prior ALT results: G#1, ALT < 40 IU/L; G#2, 40 IU/L ≤ ALT < 120 IU/L; G#3, 120 IU/L ≤ ALT < 240 IU/L; and G#4, ALT ≥ 240 IU/L. In G#1 and G#2 patients, lamivudine or adefovir treatment decreased ALT and TB compared to prior values. In G#3 and G#4 patients with three times the upper limit of normal (ULN) ≤ ALT < 15 times the ULN, both ALT and TB were decreased after treatment with lamivudine alone, or adefovir following lamivudine therapy, indicating that lamivudine therapy ameliorated liver functions. However, in G#4 patients who experienced severely advanced hepatitis (ALT ≥ 15 times the ULN, or ≥ 600 IU/L), lamivudine augmented TBmax (6.3→13.3 mg/dL) despite a slight improvement in ALT (...Continue Reading
References
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Jun 3, 1998·Journal of the American Medical Informatics Association : JAMIA·A K JhaD W Bates
Jun 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R PerrilloA Murray
Mar 10, 2001·The American Journal of Gastroenterology·A TsubotaH Kumada
Apr 24, 2001·American Journal of Therapeutics·H J Willens
Jun 8, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N W LeungUNKNOWN Asia Hepatitis Lamivudine Study Group
Jul 27, 2002·Digestive Diseases and Sciences·Herbert L BonkovskyBarbara Banner
Apr 4, 2003·JAMA : the Journal of the American Medical Association·Paul D ThompsonRichard H Karas
Apr 19, 2003·Journal of Internal Medicine·Z Ben-AriR Tur-Kaspa
Jun 17, 2003·PharmacoEconomics·Rosa Rodríguez-MonguióJoan Rovira
Dec 31, 2003·Gastroenterology·Marion G PetersCarol L Brosgart
Jul 3, 2004·BMJ : British Medical Journal·Munir PirmohamedAlasdair M Breckenridge
Apr 12, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Kevin M Korenblat, Paul D Berk
Sep 28, 2005·Pharmacotherapy·Courtney L Bickford, Anne P Spencer
Jan 3, 2006·Transplantation Proceedings·R BárcenaM Rueda
Sep 30, 2008·Drug Metabolism Reviews·Young-Mi AhSang Geon Kim
Sep 5, 2012·Expert Opinion on Drug Metabolism & Toxicology·Alessia UgliettiRenato Maserati
Feb 14, 2013·Experimental and Therapeutic Medicine·Changhong LiuCongkang Chen
Nov 9, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Andrew RowlandJohn O Miners
Jan 30, 2015·PloS One·Zhihong WanShaojie Xin
Mar 4, 2015·Srpski arhiv za celokupno lekarstvo·Antonija Verhaz
Apr 5, 2016·Drug Design, Development and Therapy·Chi ZhangYi Yang